Skip to content

CYTOSORBENTS CORPORATION: 10-Q filed 2013-11-06

What CYTOSORBENTS CORPORATION reported in its quarterly report filed 2013-11-06 (fiscal Q3 2013): 32 published measures, 95 facts as tagged in accession 0001144204-13-059215.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-06
Fiscal period
fiscal Q3 2013
Accession
0001144204-13-059215 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOSORBENTS CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-304,039,006USD
At 2012-12-313,339,408USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-09-303,065,719USD
At 2012-12-312,076,736USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-30-13,610,228USD
At 2012-12-31-11,625,145USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-302,349,994USD
At 2012-12-311,729,344USD
At 2012-09-302,061,132USD
At 2011-12-311,186,653USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-964,789USD92
2013-01-01 to 2013-09-30-4,008,720USD273
1997-01-22 to 2013-09-30-91,819,145USD6096
2012-07-01 to 2012-09-30-651,980USD92
2012-01-01 to 2012-09-30-3,125,886USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-2,386,815USD273
1997-01-22 to 2013-09-30-68,580,671USD6096
2012-01-01 to 2012-09-30-2,854,564USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-09-3033,276USD273
1997-01-22 to 2013-09-302,454,086USD6096

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-09-303,022,687USD273
1997-01-22 to 2013-09-3075,477,550USD6096
2012-01-01 to 2012-09-303,750,000USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-52,137USD273
1997-01-22 to 2013-09-30-4,571,138USD6096
2012-01-01 to 2012-09-30-20,957USD274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
1997-01-22 to 2013-09-30-939,074USD6096

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-30143,533USD
At 2012-12-31145,600USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-879,843USD92
2013-01-01 to 2013-09-30-3,708,915USD273
1997-01-22 to 2013-09-30-85,033,649USD6096
2012-07-01 to 2012-09-30-601,179USD92
2012-01-01 to 2012-09-30-2,677,908USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-303,644,064USD
At 2012-12-312,939,588USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-303,065,719USD
At 2012-12-312,076,736USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-30572,014USD
At 2012-12-31800,670USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,139,912USD92
2013-01-01 to 2013-09-304,178,731USD273
1997-01-22 to 2013-09-3087,049,053USD6096
2012-07-01 to 2012-09-301,064,676USD92
2012-01-01 to 2012-09-303,155,421USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-09-30362,542USD
At 2012-12-31682,372USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30260,069USD92
2013-01-01 to 2013-09-30469,816USD273
1997-01-22 to 2013-09-302,015,404USD6096
2012-07-01 to 2012-09-30463,497USD92
2012-01-01 to 2012-09-30477,513USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-07-01 to 2013-09-30687,788USD92
2013-01-01 to 2013-09-301,901,768USD273
1997-01-22 to 2013-09-3028,312,979USD6096
2012-07-01 to 2012-09-30359,625USD92
2012-01-01 to 2012-09-30915,402USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-07-01 to 2013-09-30294,198USD92
2013-01-01 to 2013-09-301,706,498USD273
1997-01-22 to 2013-09-3055,635,957USD6096
2012-07-01 to 2012-09-30554,266USD92
2012-01-01 to 2012-09-301,854,407USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-30245,140,613shares
At 2012-12-31214,967,503shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-3090,587,894USD
At 2012-12-3186,903,415USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-09-3024,253USD
At 2012-12-31-12,662USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-09-30251,409USD
At 2012-12-31254,220USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-09-30737,655USD
At 2012-12-31476,093USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-924,605USD92
2013-01-01 to 2013-09-30-3,971,805USD273
1997-01-22 to 2013-09-30-91,794,892USD6096
2012-07-01 to 2012-09-30-651,980USD92
2012-01-01 to 2012-09-30-3,125,886USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-1,489,937USD92
2013-01-01 to 2013-09-30-5,736,773USD273
1997-01-22 to 2013-09-30-104,469,233USD6096
2012-07-01 to 2012-09-30-1,281,705USD92
2012-01-01 to 2012-09-30-4,996,732USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
1997-01-22 to 2013-09-30183,556USD6096

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-84,946USD92
2013-01-01 to 2013-09-30-299,805USD273
1997-01-22 to 2013-09-30-7,724,570USD6096
2012-07-01 to 2012-09-30-50,801USD92
2012-01-01 to 2012-09-30-447,978USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
1997-01-22 to 2013-09-30400,490USD6096

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30142,094USD273
1997-01-22 to 2013-09-30193,873USD6096
2012-01-01 to 2012-09-3015,863USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-319,830USD273
1997-01-22 to 2013-09-30362,542USD6096
2012-01-01 to 2012-09-30194,756USD274

Inspect the source

Entity
CYTOSORBENTS CORPORATION / CIK 0001175151
Captured
2026-09-20T07:44:44.168Z
SEC response SHA-256
8bb195ec858f16302b2a8454a5ffe3eff6c1e6cd0312136a64a7a2f621b86836

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001175151.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))